. 2019 Sep 10;18(5):4629–4638. doi: 10.3892/ol.2019.10842

Table III.

Effect of SNPs in selected genes on the prognosis in patients with advanced gastric cancer.

			Log-rank P-value for PFS			Log-rank P-value for OS

Gene	SNP	Allelic change	General	Dominant	Recessive	General	Dominant	Recessive
KDR	rs7692791	T/C	0.032^a	0.009^a	0.281	0.227	0.093	0.364
	rs2305948	C/T	0.619	0.329	0.871	0.277	0.109	0.748
	rs6838752	T/C	0.097	0.137	0.053	0.203	0.254	0.095
	rs2034965	G/A	0.155	0.065	0.240	0.065	0.031	0.883
	rs13109660	G/A	0.795	0.522	0.687	0.365	0.376	0.481
	rs1870377	T/A	0.030^a	0.008^a	0.256	0.091	0.032^a	0.250
	rs1531290	A/G	0.236	0.128	0.313	0.451	0.845	0.207
NRP-1	rs2070296	G/A	0.498	0.417	0.486	0.993	0.964	0.909
	rs2804495	G/T	0.064	0.150	0.028^a	0.085	0.308	0.029
	rs2065364	G/A	0.052	0.300	0.015^a	0.113	0.587	0.037^a
PDGFβ	rs4821877	C/T	0.712	0.490	0.862	0.949	0.933	0.747
PDGFRα	rs6554162	G/A	0.513	0.322	0.751	0.501	0.413	0.561

P<0.05. KDR, kinase insert domain receptor; NRP-1, neuropilin-1; PDGF, platelet-derived growth factor; PDGFR, PDGF receptor; OS, overall survival; PFS, progression-free survival; SNP, single nucleotide polymorphism.